ID MOLT-15 AC CVCL_8150 SY Molt-15; MOLT 15; BCH-5 DR BioSample; SAMN03151632 DR cancercelllines; CVCL_8150 DR Cosmic; 913415 DR Cosmic; 1524806 DR Wikidata; Q54906346 RX PubMed=2784121; RX PubMed=2985879; RX PubMed=3159941; RX PubMed=3874327; RX PubMed=9933131; RX PubMed=10508494; RX PubMed=12592342; RX PubMed=15472075; RX PubMed=20143388; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a CTV-1 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 33 year old male patient suffering from acute myeloid leukemia. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00147. CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Gly477Ser (c.1429G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Gly831Glu (c.2492G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Ala353Val (c.1058C>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Pro447Leu (c.1340C>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Ala500Thr (c.1498G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gly1532Arg (c.4594G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Ser2523Ter (c.7568C>A); Zygosity=Heterozygous (PubMed=15472075). CC Sequence variation: Mutation; HGNC; HGNC:8804; PDGFRB; Simple; p.Met772Ile (c.2316G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys656Phe (c.1967G>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Arg75Met (c.224G>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys175Met (c.524A>T); Zygosity=Heterozygous (from parent cell line). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: T-cell; CL=CL_0000084. DI NCIt; C9142; Adult T acute lymphoblastic leukemia DI ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_1150 ! CTV-1 SX Male AG Age unspecified CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 29 // RX PubMed=12592342; DOI=10.1038/sj.leu.2402799; RA Drexler, Hans Gunther RA Dirks, Wilhelm Gerhard RA Matsuo, Yoshinobu RA MacLeod, Roderick A.F. RT "False leukemia-lymphoma cell lines: an update on over 500 cell RT lines."; RL Leukemia 17:416-426(2003). // RX PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid RT phosphatase."; RL Leuk. Res. 9:537-548(1985). // RX PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- III. RT Beta-hexosaminidase (E.C. 3.2.1.30)."; RL Leuk. Res. 9:549-559(1985). // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=2784121; DOI=10.1002/hon.2900070203; RA Drexler, Hans Gunther RA Minowada, Jun RT "Morphological, immunophenotypical and isoenzymatic profiles of human RT leukemia cells and derived T-cell lines."; RL Hematol. Oncol. 7:115-125(1989). // RX PubMed=15472075; DOI=10.1126/science.1102160; RA Weng, Andrew P. RA Ferrando, Adolfo A. RA Lee, Woojoong RA Morris, John P. 4th RA Silverman, Lewis B. RA Sanchez-Irizarry, Cheryll RA Blacklow, Stephen Charles RA Look, Alfred Thomas RA Aster, Jon Christopher RT "Activating mutations of NOTCH1 in human T cell acute lymphoblastic RT leukemia."; RL Science 306:269-271(2004). // RX PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- 1. RT Carboxylic esterase."; RL Leuk. Res. 9:209-229(1985). // RX PubMed=10508494; DOI=10.1002/(SICI)1097-0215(19991112)83:4<555::AID-IJC19>3.0.CO;2-2; RA MacLeod, Roderick A.F. RA Dirks, Wilhelm Gerhard RA Matsuo, Yoshinobu RA Kaufmann, Maren RA Milch, Herbert RA Drexler, Hans Gunther RT "Widespread intraspecies cross-contamination of human tumor cell lines RT arising at source."; RL Int. J. Cancer 83:555-563(1999). // RX PubMed=9933131; DOI=10.1016/S0145-2126(98)00133-7; RA Burger, Renate RA Hansen-Hagge, Thomas E. RA Drexler, Hans Gunther RA Gramatzki, Martin RT "Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: RT suggestion for classification by immunophenotype and T-cell receptor RT studies."; RL Leuk. Res. 23:19-27(1999). //